Literature DB >> 6140318

Prevalence and correlates of the long-term regular use of anxiolytics.

G D Mellinger, M B Balter, E H Uhlenhuth.   

Abstract

Long-term use of anxiolytics has been a cause for concern because of the possibility of dependency and other adverse consequences. In a nationally representative probability survey of adults conducted in 1979, we found that long-term use (defined as regular daily use for a year or longer) was relatively rare, occurring among 15% of all anxiolytic users--a rate of 1.6% of all adults between the ages of 18 and 79 years in the general population. The data indicate that long-term regular users tend to be older persons with high levels of emotional distress and chronic somatic health problems. They are preponderantly women, and many are sufficiently distressed to seek out other sources of help (mental health professionals and other psychotherapeutic medications) as well. The sizable majority of long-term users is being monitored by their physicians at reasonably frequent intervals. The data give little support to current stereotypes of long-term users and suggest, instead, that such use is associated with bona fide health problems that are being treated within the broader context of the health system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6140318

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  40 in total

1.  Risk factors associated with problem use of prescription drugs.

Authors:  Linda Simoni-Wastila; Gail Strickler
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

2.  An international survey of the educational activities of schools of nursing on psychoactive drugs.

Authors:  J Falkowski; A H Ghodse
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Initial benzodiazepine use and improved health-related quality of life.

Authors:  Rolf van Hulten; Bart Teeuw; Albert Bakker; Hubert G Leufkens
Journal:  Pharm World Sci       Date:  2005-02

Review 4.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

5.  Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up.

Authors:  R van Hulten; H G Leufkens; A Bakker
Journal:  Pharm World Sci       Date:  1998-04

6.  Behavioural approaches to anxiety disorders.

Authors:  L M Drummond
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

7.  Patterns and correlates of benzodiazepine use in the French general population.

Authors:  Rajaa Lagnaoui; Fanny Depont; Annie Fourrier; Abdelillah Abouelfath; Bernard Bégaud; Hélène Verdoux; Nicholas Moore
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

Review 8.  Current benzodiazepine issues.

Authors:  J H Woods; G Winger
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 9.  Addiction to benzodiazepines.

Authors:  C Salzman
Journal:  Psychiatr Q       Date:  1998

10.  Sex differences among recipients of benzodiazepines in Dutch general practice.

Authors:  F W van der Waals; J Mohrs; M Foets
Journal:  BMJ       Date:  1993-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.